Among comments submitted to FDA's docket in advance of public hearing May 31, National Organization for the Reform of Marijuana Laws' suggestions perhaps point to path ahead for agency. "Regulations governing the production, sale, quality, and marketing of these products must take place far more expeditiously in order to protect consumer safety," the group says. FDA already appealed to Congress in its notice about docket and hearing, says attorney Coleen Klasmeier. "The notice is really a comment directed to Congress."
The US Food and Drug Administration's series of broad questions to guide its consideration on using hemp and cannabidiol as dietary ingredients has attracted many responses commenting on topics outside the agency's questions.
Among the 776 comments submitted to the "Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds" docket in...
Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.
The agency says items on its Human Foods Program’s proposed agenda for guidance “to complete during 2025” include identity and safety information for NDI notifications. Its announcement also links to document about a separate key industry question, a rulemaking which would recognize NAC as a lawful
FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.
